Serum vascular endothelial growth factor A (VEGF) is elevated in patients with ovarian granulosa cell tumor (GCT), and VEGF inhibition by bevacizumab induces apoptosis in GCT in vitro.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2011-10-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/jc.2011-1812PMID 21994955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical predictors of bevacizumab-associated gastrointestinal perforation.

  2011cited by this paper
• Inhibition of VEGF induces cellular senescence in colorectal cancer cells

  2011cited by this paper
• Recent Advances in Anti-Angiogenic Therapy of Cancer

  2011cited by this paper
• Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration

  2011cited by this paper
• Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.

  2011cited by this paper
• Serum VEGF levels and tissue activation of VEGFR2/KDR receptors in patients with breast and gynecologic cancer.

  2011cited by this paper
• Adult granulosa cell tumors of the ovary: tumor dissemination pattern at primary and recurrent situation, surgical outcome.

  2010cited by this paper
• GATA4 protects granulosa cell tumors from TRAIL-induced apoptosis.

  2010cited by this paper
• The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary

  2010cited by this paper
• Biomarkers to predict the clinical efficacy of bevacizumab in cancer.

  2010cited by this paper
• Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors.

  2010cited by this paper
• Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors.

  2009cited by this paper
• Autocrine VEGF‐A/KDR loop protects epithelial ovarian carcinoma cells from anoikis

  2009cited by this paper
• Bevacizumab suppresses neuroblastoma progression in the setting of minimal disease.

  2008cited by this paper
• The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: a case report.

  2008cited by this paper
• GATA-4 regulates Bcl-2 expression in ovarian granulosa cell tumors.

  2008cited by this paper
• Response to trastuzumab, erlotinib, and bevacizumab, alone and in combination, is correlated with the level of human epidermal growth factor receptor-2 expression in human breast cancer cell lines

  2007cited by this paper
• Phosphorylated KDR can be located in the nucleus of neoplastic cells

  2006cited by this paper
• Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.

  2006cited by this paper
• High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors.

  2005cited by this paper
• Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer.

  2005cited by this paper
• Correlation between serum vascular endothelial growth factor and endostatin levels in patients with breast cancer.

  2004cited by this paper
• Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleus

  2004cited by this paper
• Vascular endothelial growth factor and its receptor, Flk-1/KDR, are cytoprotective in the extravascular compartment of the ovarian follicle.

  2004cited by this paper
• Endostatin's antiangiogenic signaling network.

  2004cited by this paper
• Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer.

  2004cited by this paper
• Granulosa cell tumor of the ovary.

  2003cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• Elevated serum endostatin is associated with poor outcome in patients with non‐Hodgkin lymphoma

  2003cited by this paper
• Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.

  2002cited by this paper
• Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor.

  2001cited by this paper
• Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.

  2001cited by this paper
• Histopathological prognostic factors of adult granulosa cell tumors of the ovary

  2001cited by this paper
• The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo

  2000cited by this paper
• Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer.

  2000cited by this paper
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society

  2000cited by this paper
• VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells.

  1999cited by this paper
• Hepatocytes as a source of collagen type XVIII endostatin.

  1998cited by this paper
• Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels.

  1997cited by this paper
• Granulosa cell tumors of the ovary: prognostic factors and outcome.

  1994cited by this paper
• Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.

  1993cited by this paper

• [Understanding biology to identify new therapeutic targets beyond chemotherapy in ovarian granulosa cell tumors].

  2025cites this paper
• Story of 20 Years of Triumph: A Case Report of Two Patients With Stage IV Granulosa Cell Tumor of the Ovary

  2024influential citation
• Effects of Thyroid Hormones on Cellular Development in Human Ovarian Granulosa Tumor Cells (KGN)

  2024cites this paper
• Serum vascular endothelial growth factor associated with the progression of granulosa cell tumor: a report of two cases

  2023cites this paper
• Bevacizumab Efficiently Inhibits VEGF-Associated Cellular Processes in Equine Umbilical Vein Endothelial Cells: An In Vitro Characterization

  2023cites this paper
• Can adjuvant chemotherapy improve the prognosis of adult ovarian granulosa cell tumors?

  2022cites this paper
• An in vitro study on the effect of bevacizumab on endothelial cell proliferation and VEGF concentration level in patients with hereditary hemorrhagic telangiectasia

  2022cites this paper
• Delta-9-tetrahydrocannabinol increases vascular endothelial growth factor (VEGF) secretion through a cyclooxygenase-dependent mechanism in rat granulosa cells.

  2022cites this paper
• Progress in the management of ovarian granulosa cell tumor: A review

  2021cites this paper
• Meigs' syndrome and adult-type granulosa cell tumor.

  2021cites this paper
• Bisphenol analogs AF and S: Effects on cell status and production of angiogenesis-related factors by COV434 human granulosa cell line.

  2021cites this paper
• Genetics and Mutational Landscape of Ovarian Sex Cord-Stromal Tumors

  2021cites this paper
• Nuclear receptor tyrosine kinase transport and functions in cancer.

  2020cites this paper
• Chitosan-Coated Lipid-Core Nanocapsules Functionalized with Gold-III and Bevacizumab Induced In Vitro Cytotoxicity against C6 Cell Line and In Vivo Potent Antiangiogenic Activity

  2020cites this paper
• Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord–Stromal Tumors: A Contemporary Review

  2020cites this paper
• Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical Trial.

  2020cites this paper
• Multimodality imaging and genomics of granulosa cell tumors

  2019cites this paper
• Emerging biomarkers in ovarian granulosa cell tumors

  2019cites this paper
• TSP‐1 is downregulated and inversely correlates with miR‐449c expression in Cushing's disease

  2019cites this paper
• Granulosa cell tumor of ovary: A systematic review of recent evidence.

  2018cites this paper
• The molecular mechanism of ovarian granulosa cell tumors

  2018cites this paper
• Kisspeptin-10 inhibits OHSS by suppressing VEGF secretion.

  2017cites this paper
• Granulosa Cell Tumors: Novel Predictors of Recurrence in Early-stage Patients

  2017cites this paper
• Pathogenesis and treatment of adult-type granulosa cell tumor of the ovary

  2017cites this paper
• Circulating levels of TNF-related apoptosis inducing-ligand are decreased in patients with large adult-type granulosa cell tumors—implications for therapeutic potential

  2016cites this paper
• Tyrosine Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of Granulosa Cell Tumors of the Ovary

  2015influential citation
• HER2 and GATA4 are new prognostic factors for early-stage ovarian granulosa cell tumor—a long-term follow-up study

  2014cites this paper
• Regulation of Normal and Neoplastic Steroidogenic Cell Differentiation in the Adrenal Gland and Ovary

  2014cites this paper
• Serum vascular endothelial growth factor-A (VEGF-A) as a biomarker in squamous cell carcinoma of head and neck patients undergoing chemoradiotherapy.

  2014cites this paper
• Receptor Tyrosine Kinases in the Nucleus: Nuclear Functions and Therapeutic Implications in Cancers

  2014cites this paper
• Anti-VEGFA Therapy Reduces Tumor Growth and Extends Survival in a Murine Model of Ovarian Granulosa Cell Tumor.

  2013cites this paper
• Effects of an Inhibitor of the Gamma-Secretase Complex on Proliferation and Apoptotic Parameters in a FOXL2-Mutated Granulosa Tumor Cell Line (KGN)1

  2013cites this paper
• Cancer drugs : highlighting the molecular mechanisms of cardiotoxicity : commentary

  2012cites this paper
• In search of new prognostic molecular markers in ovarian cancer

  2012cites this paper